Sialylation of N-Linked glycans influences the immunomodulatory effects of IgM on T cells

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 151-157

  Colucci, Manuela ^a   Stöckmann, Henning ^b   Butera, Alessia ^a   Masotti, Andrea ^a   Baldassarre, Antonella ^a   Giorda, Ezio ^a   Petrini, Stefania ^a   Rudd, Pauline M ^b   Sitia, Roberto ^c   Emma, Francesco ^a   Vivarelli, Marina ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; IMMUNOGLOBULIN M; SIALIC ACID; IMMUNOLOGIC FACTOR; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE;

ARTICLE; BLOOD BUFFY COAT; CELL INTERACTION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERNALIZATION; MOLECULAR RECOGNITION; PROTEIN BINDING; SIALYLATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GLYCOSYLATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN TRANSPORT;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; PROTEIN TRANSPORT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84919667696     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402025     Document Type: Article

References (36)

1. Ehrenstein, M. R., and C. A. Notley. 2010. The importance of natural IgM: Scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
2. Randall, T. D., J.W. Brewer, and R. B. Corley. 1992. Direct evidence that J chain regulates the polymeric structure of IgM in antibody-secreting B cells. J. Biol. Chem. 267: 18002-18007.
3. Muller, R., M. A. Gräwert, T. Kern, T. Madl, J. Peschek, M. Sattler, M. Groll, and J. Buchner. 2013. High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation. Proc. Natl. Acad. Sci. USA 110: 10183-10188.
4. Kaveri, S. V., G. J. Silverman, and J. Bayry. 2012. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J. Immunol. 188: 939-945.
5. Dorsett, B., W. Cronin, V. Chuma, and H. L. Ioachim. 1985. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Am. J. Med. 78: 621-626.
6. Lobo, P. I. 1981. Nature of autolymphocytotoxins present in renal hemodialysis patients: Their possible role in controlling alloantibody formation. Transplantation 32: 233-237.
7. Winfield, J. B., P. D. Fernsten, and J. K. Czyzyk. 1997. Anti-lymphocyte autoantibodies in systemic lupus erythematosus. Trans. Am. Clin. Climatol. Assoc. 108: 127-135.
8. Lobo, P. I., K. H. Schlegel, C. E. Spencer, M. D. Okusa, C. Chisholm, N. McHedlishvili, A. Park, C. Christ, and C. Burtner. 2008. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J. Immunol. 180: 1780-1791.
9. Lobo, P. I., K. H. Schlegal, J. Vengal, M. D. Okusa, and H. Pei. 2010. Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. J. Clin. Immunol. 30(Suppl. 1): S31-S36.
10. Lobo, P. I., A. Bajwa, K. H. Schlegel, J. Vengal, S. J. Lee, L. Huang, H. Ye, U. Deshmukh, T. Wang, H. Pei, and M. D. Okusa. 2012. Natural IgM antileukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J. Immunol. 188: 1675-1685.
11. Chhabra, P., K. Schlegel, M. D. Okusa, P. I. Lobo, and K. L. Brayman. 2012. Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation. Ann. Surg. 256: 634-641.
12. Lobo, P. I., K. L. Brayman, and M. D. Okusa. 2014. Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J. Clin. Immunol. 34(Suppl. 1): S22-S29.
13. Schwab, I., and F. Nimmerjahn. 2013. Intravenous immunoglobulin therapy: How does IgG modulate the immune system? Nat. Rev. Immunol. 13: 176-189.
14. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
15. Stöckmann, H., B. Adamczyk, J. Hayes, and P. M. Rudd. 2013. Automated, high-throughput IgG-Antibody glycoprofiling platform. Anal. Chem. 85: 8841-8849.
16. Harvey, D. J., A. H. Merry, L. Royle, M. P. Campbell, R. A. Dwek, and P. M. Rudd. 2009. Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics 9: 3796-3801.
17. Silverman, G. J., J. Vas, and C. Grönwall. 2013. Protective autoantibodies in the rheumatic diseases: Lessons for therapy. Nat. Rev. Rheumatol. 9: 291-300.
18. Wu, X., N. Okada, M. Iwamori, and H. Okada. 1996. IgM natural antibody against an asialo-oligosaccharide, gangliotetraose (Gg4), sensitizes HIV-I infected cells for cytolysis by homologous complement. Int. Immunol. 8: 153-158.
19. Mimura, T., P. Fernsten, M. Shaw, W. Jarjour, and J. B. Winfield. 1990. Glycoprotein specificity of cold-reactive IgM antilymphocyte autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 33: 1226-1232.
20. Johansen, F. E., R. Braathen, and P. Brandtzaeg. 2001. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167: 5185-5192.
21. Petrusić, V., I. Zivković, M. Stojanović, I. Stojićević, E. Marinković, A. Inić- Kanada, and L. Dimitijević. 2011. Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers. Immunol. Res. 51: 97-107.
22. Arnold, J. N., M. R. Wormald, D. M. Suter, C. M. Radcliffe, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. B. Sim. 2005. Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J. Biol. Chem. 280: 29080-29087.
23. Hess, C., A. Winkler, A. K. Lorenz, V. Holecska, V. Blanchard, S. Eiglmeier, A. L. Schoen, J. Bitterling, A. D. Stoehr, D. Petzold, et al. 2013. T cellindependent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 123: 3788-3796.
24. Goulabchand, R., T. Vincent, F. Batteux, J. F. Eliaou, and P. Guilpain. 2014. Impact of autoantibody glycosylation in autoimmune diseases. Autoimmun. Rev. 13: 742-750.
25. Kaneko, Y., F. Nimmerjahn, and J. V. Ravetch. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673.
26. Schwab, I., M. Biburger, G. Krönke, G. Schett, and F. Nimmerjahn. 2012. IVIgmediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1. Eur. J. Immunol. 42: 826-830.
27. Schwab, I., S. Mihai, M. Seeling, M. Kasperkiewicz, R. J. Ludwig, and F. Nimmerjahn. 2014. Broad requirement for terminal sialic acid residues and FcgRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. Eur. J. Immunol. 44: 1444-1453.
28. Massoud, A. H., M. Yona, D. Xue, F. Chouiali, H. Alturaihi, A. Ablona, W.Mourad, C. A. Piccirillo, and B. D.Mazer. 2014. Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J. Allergy Clin. Immunol. 133: 853-863.e5.
29. Seite, J. F., C. Goutsmedt, P. Youinou, J. O. Pers, and S. Hillion. 2014. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J. Allergy Clin. Immunol. 133: 181-188.e1-9.
30. Ferrarini, M., L. Moretta, R. Abrile, and M. L. Durante. 1975. Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur. J. Immunol. 5: 70-72.
31. Moretta, L., M. Ferrarini, M. L. Durante, and M. C. Mingari. 1975. Expression of a receptor for IgM by human T cells in vitro. Eur. J. Immunol. 5: 565-569.
32. Mingari, M. C., L. Moretta, A. Moretta, M. Ferrarini, and J. L. Preud'homme. 1978. Fc-receptors for IgG and IgM immunoglobulins on human T lymphocytes: Mode of re-expression after proteolysis or interaction with immune complexes. J. Immunol. 121: 767-770.
33. Klimovich, V. B. 2011. IgM and its receptors: Structural and functional aspects. Biochemistry 76: 534-549.
34. Kubagawa, H., S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D. W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al. 2009. Identity of the elusive IgM Fc receptor (FcmuR) in humans. J. Exp. Med. 206: 2779-2793.
35. Vire, B., A. David, and A.Wiestner. 2011. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J. Immunol. 187: 4040-4050.
36. Kubagawa, H., S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D. W. Kang, D. Jones, N. Nishida, T. Miyawaki, L. F. Bertoli, et al. 2014. The long elusive IgM Fc receptor, FcmR. J. Clin. Immunol. 34(Suppl. 1): S35-S45.